SIK1 and pulmonary arterial hypertension: As SIKs coordinate signaling pathways implicated in vasoconstriction, inflammation, and vascular remodeling, it has been proposed that the dysregulation of SIK pathways might underpin the pathophysiology of PAH (António et al., 2022).